Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

2026 Autoimmune Neurology Conference | Industry Therapeutic Update from argenx: New frontiers in myositis: From autoantibodies to FcRn blockade

Saturday 08/08/26
07:00 AM - 08:00 AM CDT Add To Calendar
This program will be presented in-person only
This program is not expected to be available in the meeting's On Demand product.
Industry Therapeutic Update
General Neurology
Expert faculty will review the complex and heterogeneous pathophysiology of this group of diseases, with a focus on the role of autoantibodies in diagnosis and prognosis. The session will also examine the contribution of IgG autoantibodies to myositis pathogenesis and how these mechanistic insights are being investigated to support the potential of FcRn blockade as a targeted therapeutic approach.
No CME available
Event Timeline
07:00 AM - 08:00 AM CDT Speaker Industry Therapeutic Update from argenx: New frontiers in myositis: From autoantibodies to FcRn blockade
Faculty Disclosures
Arjun Seth, MD Dr. Seth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Seth has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB Pharma. Dr. Seth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. Dr. Seth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Seth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi.
Eleni Tiniakou, MD No disclosure on file